# Caliway's CBL-514 Receives Early IND Clearance in China, Accelerating Development in the World's Fastest-Growing Body Contouring Market

- Source: PR Newswire M&A
- Published: 2026-11-20T05:14:00+00:00
- Category: Business
- Original: https://www.prnewswire.com/news-releases/caliways-cbl-514-receives-early-ind-clearance-in-china-accelerating-development-in-the-worlds-fastest-growing-body-contouring-market-302946515.html
- Canonical: https://groundlevelnews.com/story/caliway-s-cbl-514-receives-early-ind-clearance-in-china-accelerating-d-932402/

China Clinical Trial Cleared Ahead of Schedule—CBL-514's China clinical study (CBL-0102) received authorization to proceed from the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) ahead of the anticipated timeline, reflecting regulatory...

_Ground Level News shows a short summary only; the full article and all rights belong to PR Newswire M&A._
